Curated content that matters
Explore stories across diverse categories
Samsung is making a major push into precision medicine, investing $110 million in U.S.-based biotech company GRAIL, which
Samsung is preparing to unveil its long-awaited Galaxy XR headset, signaling its return to the extended reality (XR)
Binance, the world’s largest cryptocurrency exchange, is making a strategic push into South Korea just months after resolving
South Korea’s LG Energy Solution, one of the world’s largest EV battery manufacturers, is deepening its foothold in
Photo=CJ Logistics CJ Logistics, one of South Korea’s leading logistics companies, announced Thursday that it has begun field trials of AI-powered humanoid robots, becoming the first logistics firm in the country to implement such technology in operational settings. The company has partnered with robotics specialist Robotis to jointly develop “Physical AI,” an artificial intelligence system that goes beyond digital environments
Samsung Electronics is expanding its SmartThings platform with new safety tools and tighter integration with Hyundai Motor Group vehicles, aiming to make the connected home ecosystem more central to everyday life. The company said Wednesday that the latest SmartThings update introduces SmartThings Safe, a feature designed to address rising concerns tied to single-person households and an aging population. Users can
(Photo=Pixabay) South Korea is showing signs of demographic recovery, with both births and marriages increasing in July—a rare uptick for a country long grappling with one of the world’s lowest fertility rates. Statistics Korea reported 21,803 births in July, up 5.9% from a year earlier and the highest July total since 2021. Births have now grown year-over-year for 13 consecutive
South Korea’s consumer confidence slipped in September for the first time in half a year, as concerns over U.S. tariffs and a sluggish construction sector weighed on households. The Bank of Korea said Tuesday its composite consumer sentiment index (CCSI) fell to 110.1 in September, down from 111.4 in August, ending a five-month streak of gains. The index had plunged
Donald Trump’s recent claim that Tylenol use during pregnancy could raise the risk of autism isn’t just rattling U.S. drugmakers—it’s causing anxiety among pharmaceutical companies halfway around the world. At a Sept. 22 White House press conference, Trump said “new findings” showed acetaminophen, Tylenol’s active ingredient, might harm unborn children. He suggested the FDA would alert doctors, though no such
